Rapaccini, Gian Ludovico
 Distribuzione geografica
Continente #
EU - Europa 6.408
NA - Nord America 5.706
AS - Asia 1.830
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 20
SA - Sud America 19
OC - Oceania 14
Totale 14.041
Nazione #
US - Stati Uniti d'America 5.674
DE - Germania 2.482
SE - Svezia 1.314
CN - Cina 867
UA - Ucraina 568
IT - Italia 562
IE - Irlanda 416
SG - Singapore 396
FR - Francia 278
ID - Indonesia 226
GB - Regno Unito 217
FI - Finlandia 194
RU - Federazione Russa 144
TR - Turchia 114
IN - India 113
PL - Polonia 64
BE - Belgio 47
CI - Costa d'Avorio 35
JP - Giappone 31
CZ - Repubblica Ceca 22
CH - Svizzera 18
IR - Iran 18
NL - Olanda 18
HK - Hong Kong 17
EU - Europa 16
CA - Canada 15
VN - Vietnam 14
BZ - Belize 13
RO - Romania 13
AU - Australia 11
TW - Taiwan 11
BR - Brasile 9
ES - Italia 7
GR - Grecia 7
PT - Portogallo 7
AT - Austria 6
CL - Cile 6
DK - Danimarca 5
KR - Corea 5
HU - Ungheria 4
KZ - Kazakistan 3
MX - Messico 3
NZ - Nuova Zelanda 3
SC - Seychelles 3
A1 - Anonimo 2
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
BY - Bielorussia 2
EE - Estonia 2
IL - Israele 2
MK - Macedonia 2
NO - Norvegia 2
PH - Filippine 2
RE - Reunion 2
SD - Sudan 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
EC - Ecuador 1
EG - Egitto 1
IQ - Iraq 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MM - Myanmar 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 14.041
Città #
Chandler 1.208
Ashburn 447
Dublin 415
Jacksonville 320
Singapore 291
New York 256
San Mateo 250
Nanjing 230
Jakarta 226
Ann Arbor 163
Nürnberg 162
Wilmington 156
Boston 142
Dearborn 139
Houston 128
Princeton 125
Moscow 110
Izmir 102
Milan 102
Chicago 99
Marseille 99
Cattolica 87
Los Angeles 85
Beijing 82
Helsinki 81
Woodbridge 79
Munich 71
Nanchang 69
Bremen 61
Redwood City 61
Redmond 60
Seattle 59
Rome 58
Fairfield 52
Kraków 52
Boardman 47
Shenyang 46
Brussels 45
San Jose 42
Lawrence 41
Hebei 38
Lancaster 36
Abidjan 35
Mountain View 34
Norwalk 33
Tianjin 33
Zhengzhou 31
Kunming 30
University Park 29
Hangzhou 28
Pune 27
Changsha 25
Leawood 24
Augusta 23
Bologna 23
Jiaxing 22
Guangzhou 20
Falls Church 19
Jinan 19
Detroit 18
Shanghai 18
Edinburgh 17
Las Vegas 17
Brno 16
Buffalo 14
Castelnuovo di Val di Cecina 14
Hong Kong 14
Belize City 13
Hanoi 13
Washington 13
Fremont 12
Hefei 12
Lanzhou 12
Warsaw 12
Andover 11
London 11
Cambridge 10
Tokyo 10
Zurich 10
Atlanta 9
Costa Mesa 9
Kish 9
San Diego 9
Simi Valley 9
Taipei 9
Auburn Hills 8
Changchun 8
Phoenix 8
Portland 8
Boydton 7
Cagliari 7
Sacramento 7
Taizhou 7
Albuquerque 6
Bern 6
Busto Arsizio 6
Kocaeli 6
Lappeenranta 6
Nuremberg 6
Saint Louis 6
Totale 7.300
Nome #
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 385
Association between Klinefelter syndrome and focal nodular hyperplasia 260
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 207
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 183
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 180
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 179
Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma <= 3 cm. Results of a multicenter Italian survey. 178
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 159
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 154
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 150
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 143
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 142
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. 142
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 142
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 142
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 139
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants. 135
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study 135
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 133
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 130
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis. 129
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 125
recurrent acute hepatitis associated with use of cetrizine 125
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 125
A case of non-occlusive mesenteric ischemia and hepatic portal venous gas: not everyone knows that… 122
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 122
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 120
Potential use of liver function breath tests in the clinical practice. 118
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 115
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 110
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 104
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 98
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection 97
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 97
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year. 97
Magnesium Absorption in Intestinal Cells: Evidence of Cross-Talk between EGF and TRPM6 and Novel Implications for Cetuximab Therapy 97
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 96
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 96
DNA ploidy pattern in human chronic liver diseases and hepatic nodular lesions. Flow cytometric analysis on echo-guided needle liver biopsy 91
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 91
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 91
Severe Skin Burn at Needle Entry Point Complicating Radiofrequency Ablation for Hepatocellular Carcinoma 90
Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma 90
Doppler ultrasonographic evaluation of blood flow in the superior mesenteric artery in celiac patients and in healthy controls in fasting conditions and after saccharose ingestion 90
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 89
Liver transplantation in patients with alcoholic liver disease: A retrospective study 89
Lipohyperplasia of the ileocaecal valve as a cause of intestinal haemorrhage: an ultrasound Doppler study 88
Gastric wall thickness in normal and neoplastic subjects: a prospective study performed by abdominal ultrasound 88
Single Hepatocellular Carcinoma Smaller than 2 cm: Are Ethanol Injection and Radiofrequency Ablation Equally Effective? 88
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study 87
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases 87
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 85
[Liver transplantation] 84
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. 84
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. 80
Immunological role of IgG subclasses 80
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. 78
Amantadine-induced livedo reticularis occurring during treatment of chronic hepatitis C 78
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 78
Contrast-enhanced power doppler of the intestinal wall in the evaluation of patients with Crohn disease 77
Botulinum toxin-B ultrasound-guided injections for sialorrhea in amytrophic lateral sclerosis and Parkinson's disease 76
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 76
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 76
Is coeliac disease a confounding factor in the diagnosis of NASH? 75
Liver transplantation in Italy: preliminary 10-year report. The Monotematica Aisf-Olt Study Group 75
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 75
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 75
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 74
Clinical suspicion of pancreatic neoplasm: does echo-guided fine-needle biopsy modify patient management? 73
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 73
Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis 72
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 71
Sarilumab use in severe SARS-CoV-2 pneumonia 71
Impairment of recent thymic emigrants in HCV infection. 70
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing 69
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 68
Bridge treatments of hepatocellular carcinoma in cirrhotic patients submitted to liver transplantation 67
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome 67
Acute hepatitis associated with use of paroxetine 66
Neoplastic seeding complicating percutaneous ethanol injection for treatment of hepatocellular carcinoma 66
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 66
Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity 66
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 66
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 66
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 66
Cruveilhier-Baumgarten syndrome: an efficient spontaneous portosystemic collateral preventing oesophageal varices bleeding 65
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma 65
Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation 64
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 64
Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy 63
Primary neoplasm of the duodenum diagnosed by echo-guided fine-needle biopsy 63
Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk 63
The Laboratory Role in anti-TNF Biological Therapy Era 63
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 63
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 62
Development and validation of predictive assessment of complicated diverticulitis score 62
Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel diseases 61
Long-term effectiveness of Radiofrequency Ablation for solitary small Hepatocellular Carcinoma: A retrospective analysis of 363 patients 61
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 61
Recurrent acute hepatitis associated with use of cetirizine 60
Totale 9.999
Categoria #
all - tutte 62.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.129 0 0 0 58 144 207 150 82 103 109 139 137
2020/20211.225 67 114 46 141 149 41 115 28 168 58 260 38
2021/20221.642 110 118 39 140 102 54 34 221 66 107 283 368
2022/20233.736 476 436 268 501 296 434 227 314 446 97 163 78
2023/20242.071 115 556 64 135 82 355 113 88 26 125 160 252
2024/2025602 108 107 379 8 0 0 0 0 0 0 0 0
Totale 14.305